medroxyprogesterone acetate has been researched along with Injuries, Spinal Cord in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albayrak, BS; Gorgulu, A; Ismailoglu, O; Sahin, B | 1 |
| Akdemir, I; Erol, FS; Gursu, F; Kaplan, M; Kilic, N; Tiftikci, M; Topsakal, C | 1 |
2 other study(ies) available for medroxyprogesterone acetate and Injuries, Spinal Cord
| Article | Year |
|---|---|
The effects of medroxy progesterone acetate on the pro-inflammatory cytokines, TNF-alpha and IL-1beta in the early phase of the spinal cord injury.
Topics: Animals; Disease Models, Animal; Drug Evaluation, Preclinical; Interleukin-1beta; Male; Medroxyprogesterone Acetate; Rats; Rats, Wistar; Spinal Cord Injuries; Time Factors; Tumor Necrosis Factor-alpha | 2011 |
Medroxyprogesterone acetate, enoxaparin and pentoxyfylline cause alterations in lipid peroxidation, paraoxonase (PON1) activities and homocysteine levels in the acute oxidative stress in an experimental model of spinal cord injury.
Topics: Animals; Antioxidants; Enoxaparin; Homocysteine; Lipid Peroxidation; Male; Medroxyprogesterone Acetate; Oxidative Stress; Pentoxifylline; Rats; Rats, Wistar; Spinal Cord; Spinal Cord Compression; Spinal Cord Injuries; Spinal Cord Ischemia | 2002 |